Sabril (vigabatrin) Briefing Materials
For the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
Briefing Materials
- SABRIL Labeling, 9/18/2015
- SABRIL Safety and Drug Utilization Review
- Pediatric Focused Safety Review: Sabril (vigabatrin)
- SABRIL Clinical Review
- SABRIL Clinical Pharmacology Review
- SABRIL Statistical Review